IL10 and myeloid sarcoma: In the analysis of serum CKs, OVA-treated mice exhibited increased IL-5 and IL-10 secretion in serum, while MS treatment attenuated IL-5 elevation but enhanced IL-10 elevation (Figure 2(f)).